Introduction {#sec1-1}
============

Defects in palatogenesis are of complex etiology and represent some of the most common congenital malformations in humans, with an average prevalence of 1.2:1000 live births worldwide.\[[@ref1]--[@ref5]\] The mechanisms involved in this process depend on a tightly regulated network of signaling molecules that control cell proliferation, apoptosis, and skeletal differentiation during development.\[[@ref6]--[@ref15]\] Recent studies indicate that microRNAs (miRNAs), a highly conserved class of small noncoding RNAs, regulate gene expression by repressing protein translation or inducing mRNA degradation. Mature miRNAs are single-stranded RNAs (ssRNAs) of approximately 22 nucleotides in length, generated by DICER1, an RNAse III family member.\[[@ref16][@ref17]\]

*DICER1* deletion disrupts numerous physiological processes that are dependent on miRNA-mediated gene regulation and is associated with early embryonic lethality.\[[@ref18]--[@ref30]\] Human studies investigating the role of *DICER1* during palatogenesis are limited. Previously, a genome-wide scan for nonsyndromic cleft lip and palate in multigenerational Indian families suggested evidence of linkage at several chromosomes regions including 14q32, which comprises the genomic location of *DICER1*.\[[@ref31]\] More recently, Li, *et al*.\[[@ref32]\] showed that rs7205289 in pre-miR-140, which had been previously implicated in zebrafish palatogenesis,\[[@ref33]\] may contribute to human nonsyndromic cleft palate susceptibility by influencing the processing of mature miR-140. Although groundbreaking, these studies highlight the need for additional analyses on the expression of *DICER1* and its dependent miRNAs, as well as their regulatory function during mammalian palatogenesis and orofacial development.

To investigate *Dicer1* function during palatal and orofacial morphogenesis, we utilized a *Dicer1* conditional knockout (CKO) mouse model in which the floxed *Dicer1* alleles are deleted through *Cre*-mediated recombination following *Pax2-Cre* expression.\[[@ref26][@ref30][@ref34]\] *Pax2* is the earliest transcription factor to be expressed in the prospective mid-hindbrain area, around embryonic (E) day 7.5 in mouse\[[@ref34]--[@ref37]\] and as such may affect cranial neural crest cell (CNC) migration, proliferation, and the differentiation of CNC-derived tissues, including the formation of skeletal structures associated with the craniofacial region.\[[@ref38]\]

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Animals {#sec3-1}

All animal care and use was approved by the Creighton University Institutional Animal Care and Use Committee (IACUC). *Pax2-Cre/Dicer1^loxP/loxP^* CKO mice were generated as previously described.\[[@ref30]\] Control animals consisted of *Dicer1^loxP/loxP^* mice not carrying the *Pax2-Cre* transgene. To examine *Pax2-Cre* expression domains, *Dicer1^loxP/loxP^* was mated with *Pax2-Cre/Rosa26R* females. Timed pregnancies were set up overnight. Noon of the next day was considered embryonic day 0.5, and pregnancies were counted forward from that point. Embryos were harvested by caesarean section at different stages of embryonic development.

### H and E staining and whole-mount skeletal staining {#sec3-2}

Hematoxylin-Eosin (H and E) staining, whole-mount skeletal staining, and Von Kossa staining were performed as described elsewhere.\[[@ref39][@ref40]\]

### *In situ* hybridization and quantitative real time-PCR {#sec3-3}

*Dicer1* ISH was performed as previously described.\[[@ref30]\] Gene-specific RT-QPCR on total RNA isolated from palatal tissue was performed as described elsewhere.\[[@ref41]\] Detection of miR-101b, miR-140, and miR-145 (Exiqon, Inc. Woburn, MA, USA) was performed as described by Weston and colleagues.\[[@ref42]\] Student\'s *t*-test was performed on normalized miRNA expression values to assess statistical significance (*P* ≤ 0.01 was considered significant).

### Proliferation assays {#sec3-4}

Labeling and detection of mitotically active cells by the thymidine analog 5-ethynyl-2'-deoxyuridine (EdU) (50 mg/kg) in DMSO was performed as previously described.\[[@ref41][@ref43]\] Negative controls consisted of saline-injected females. Five animals per genotype and time point were analyzed. The number of EdU-positive cells were counted. Student\'s *t*-test was performed, *P* ≤ 0.01 was considered significant.

### Apoptosis assay {#sec3-5}

Coronal sections (10 μm) from WT and *Dicer1* CKO at different embryonic time points were processed using the ApopTag Plus *In situ* apoptosis fluorescein detection kit (Chemicon International, Inc. Temecula, CA, USA) and counterstained with DAPI. Control tissue sections were treated with DNase I (positive control) or DNase I buffer without the enzyme (negative control), before the ApopTag reaction. Counting of apoptotic nuclei was performed at 20μm intervals. Five cross-sections were analyzed per genotype. Four areas (120 μm × 120 μm) were selected within cross-sections. The ratio of fluorescein-positive nuclei to the total (DAPI-stained) nuclei was calculated per section. Student\'s *t*-test was performed, *P* ≤ 0.01 was considered significant.

Results {#sec1-3}
=======

 {#sec2-2}

### Pax2-Cre-mediated Dicer1 deletion induces embryonic lethality and craniofacial abnormalities {#sec3-6}

*Dicer1* ablation in the *Pax2-Cre* expression domain results in impaired growth of the mid-hindbrain and late embryonic lethality at E18.5.\[[@ref30]\] Gross morphological analyses of E17.5 *Dicer1* CKO mutants revealed micrognathia, midface hypoplasia, exophthalmos due to shallow orbits, absence in eyelid formation, and reduction in cranial vault size \[Figures [1a](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}\]. Slight phenotypic variations also noted in the craniofacial region of mutant embryos include frontal bossing and cerebral haemorrhage \[[Figure 1b](#F1){ref-type="fig"}\].

![*Pax2-Cre*-mediated deletion of *Dicer1* results in craniofacial abnormalities and secondary palatal cleft. a, c. Frontal and lateral views of WT mice. b, d. Frontal and lateral views of *Dicer* CKO mouse. Bar = 2mm](IJHG-18-310-g001){#F1}

### Expression of Pax2-Cre and Dicer1 microRNAs during palatal shelf development {#sec3-7}

To determine the pattern of *Pax2-Cre* expression in the embryonic orofacial region, *Pax2-Cre/Dicer1^loxP/WT^* mice at E12.5 and E17.5 and *Dicer1* CKO mice at E17.5, all of them carrying a *Rosa26-LacZ* reporter allele (*Rosa26R*), were examined by X-gal staining. At E12.5, X-gal staining, which highlights all progeny of the *Pax2-Cre*-expressing cells, shows positive cells throughout the mid-hindbrain and in the region of the first pharyngeal arch of the *Pax2-Cre/Dicer1^loxP/WT^/Rosa26R*, including the developing palatal shelves \[Figures [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. At E17.5, *Pax2-Cre*-positive cells continued to be expressed in the mid-hindbrain\[[@ref30]\] and throughout the secondary palate in the *Pax2-Cre/Dicer1^loxP/WT^/Rosa26R* \[[Figure 2c](#F2){ref-type="fig"}\], while *Dicer* CKO mice exhibited diminished X-gal staining and a complete cleft of the secondary palate \[[Figure 2d](#F2){ref-type="fig"}\].

![X - gal staining in *Pax2-Cre/DicerloxP/WT/Rosa26R* (a-c) and *Dicer1* CKO (d) mice. MHB: mid-hindbrain; PS: palatal shelf; NC: nasal cavity; NS: nasal septum; PP: primary palate; SP: secondary palate. Bar = 50 μm (a, b); 1mm (c, d). Palatal rim delineated by dotted line](IJHG-18-310-g002){#F2}

To confirm *Pax2-Cre*-mediated *Dicer1* deletion in a spatially restricted pattern, we generated a *Dicer1* riboprobe and examined its expression by ISH in WT and *Dicer1* CKO mice at E12.5 \[[Figure 3](#F3){ref-type="fig"}\]. Compared to the WT \[Figures [3a](#F3){ref-type="fig"}, [c](#F3){ref-type="fig"} and [e](#F3){ref-type="fig"}\], only residual *Dicer1* expression was observed in the mid-hindbrain, brainstem, and palatal shelves \[Figures [3b](#F3){ref-type="fig"}, [d](#F3){ref-type="fig"}, and [f](#F3){ref-type="fig"}\], which corresponds to the *Pax2-Cre* expression domain.

![*In situ* hybridization with *Dicer1* probe at E12.5. a-b. Head. c-d. Palate. e-f. Brain. HB: hindbrain; MB: midbrain; FB: forebrain; PP: primary palate; PS: palatal shelves; NC: nasal cavity. Bar = 50 μm (a--d); 2 mm (e--f). Palatal rim delineated](IJHG-18-310-g003){#F3}

### Palatogenesis in the *Dicer1* conditional knockout mouse {#sec3-8}

To assess the stage at which morphological differences first occur during the *Dicer1* CKO palatal development, E11.5, E13.5, and E16.5 WT control and *Dicer1* CKO mutant mouse heads were coronally sectioned and stained with H and E. At E11.5, coronal sections showed comparable orofacial and palatal morphology in both mutant and WT embryos, suggesting that, prior to E11.5, orofacial development is not impacted by *Dicer1* loss \[Figures [4a](#F4){ref-type="fig"} and [b](#F4){ref-type="fig"}\]. Although *Pax2-Cre* expression in mice has been shown to start as early as one somite stage\[[@ref37]\] morphological differences in palatal development did not become conspicuous until around E13.5. At this stage, the palatal shelves of *Dicer1* CKO embryos are vertically positioned along the side of the tongue, in a pattern similar to the control embryos. Nevertheless, the palatal shelves in *Dicer1* CKO embryos exhibit a slight reduction in size, suggesting developmental delay in bilateral palatal outgrowth of the maxillary process \[Figures [4c](#F4){ref-type="fig"} and [d](#F4){ref-type="fig"}\]. At E16.5, control embryos showed completion of palatal development, which is hallmarked by fusion between the palatal shelves, disappearance of the medial epithelial seam, and fusion with the primary palate anteriorly \[[Figure 4e](#F4){ref-type="fig"}\]. In addition, intramembranous ossification of the palatal bones is visible. In comparison, E16.5 *Dicer1* CKO mice showed normal primary palatal development, but exhibited a complete secondary palatal cleft \[[Figure 2d](#F2){ref-type="fig"}\]. Further histological analysis of the *Dicer1* CKO shows that the palatal shelves exhibit arrested growth, remaining vertically oriented in position \[[Figure 4f](#F4){ref-type="fig"}\], and are morphologically equivalent to an E13.5 WT embryo \[Figures [4d](#F4){ref-type="fig"} and [f](#F4){ref-type="fig"}\]. Furthermore, intramembranous ossification is completely absent at the palatal shelf region, although the nasal septal cartilage, that develops from the *Pax2-Cre*-negative frontonasal region, is present \[[Figure 4f](#F4){ref-type="fig"}\]. Collectively, the present results show that *Dicer1* deletion by *Pax2-Cre* does not affect primary palatal development, nor does it impact the initial stage of palatal development; however, it disrupts the growth and fusion of the palatal shelves.

![Comparative palatal development. a, c, e. WT. b, d, f. *Dicer1* CKO. NT: neural tube; MP: mandibular process; PS: palatal shelves; OC: oral cavity; P: secondary palate; NS: nasal septum; T: tongue. Bar = 1mm (a, b); 500 μm (c-f). H and E staining](IJHG-18-310-g004){#F4}

### CNC-derived facial and anterior skull bone development in the Dicer1 CKO {#sec3-9}

To assess cartilage and bone development E17.5 *Dicer1* CKO mice and WT littermates were stained with Alcian Blue and Alizarin Red, respectively. Compared to the WT, *Dicer1* CKO exhibited complete loss or abrogated development of several CNC-derived bones in the viscerocranium, anterior cranial vault, and prechordal skull base \[Figures [5a](#F5){ref-type="fig"}--[e](#F5){ref-type="fig"}\]. Specifically in the facial skeleton, the squamosal, jugal (zygoma), and palatine bones of the maxilla were absent, while the mandible, tympanic ring, vomer, and frontal process of the maxilla were reduced in size when compared to WT littermates \[Figures [5c](#F5){ref-type="fig"} and [d](#F5){ref-type="fig"}\]. In the anterior part of the skull, the presphenoid, alisphenoid, and orbitospheniod were absent from the cranial base, while the medial portion of the frontal bones in the calvaria and the basiosphenoid of the cranial base exhibited impaired growth \[[Figure 6d](#F6){ref-type="fig"}\]. No differences were observed between *Dicer1* CKO and WT mice in mesodermally derived skeletal elements of the posterior skull, including the parietal, intraparietal, petrous temporal, basioccipital, exoccipital, and supraoccipital \[Figures [5c](#F5){ref-type="fig"}--[f](#F5){ref-type="fig"}\]. Collectively, the observed pattern of skeletal abnormalities suggest that *Pax2-Cre*-mediated *Dicer1* deletion disrupts intramembranous and endochondral bone ossification of specific CNC-derived skeletal elements in the region of the first pharyngeal arch and anterior skull.

![*Dicer1* CKO cranioskeletal staining. NB: nasal bone; PX: premaxilla; MX: maxilla; F: frontal; PA: parietal; Z: zygoma; T: temporal; TR: tympanic ring; M: mandible; IP: intraparietal; EO: exoccipital; V: vomer; P: palatine; PS: presphenoid; BS: basiphenoid; HB: hyoid. Bar = 2 mm](IJHG-18-310-g005){#F5}

To determine the pattern of mineralization during bone formation, tissue sections from the heads of E17.5 WT and *Dicer1* CKO embryos were analyzed with Von Kossa stain. WT mice demonstrated normal intramembranous and endochondral ossification with mineral deposition in the secondary palate, mandible, and premaxilla \[Figures [6a](#F6){ref-type="fig"} and [c](#F6){ref-type="fig"}\]. In contrast, in the region of the presumptive secondary palate, *Dicer1* CKO showed only limited mesenchymal condensation and a complete absence of mineralization in the truncated palatal shelves \[Figures [6b](#F6){ref-type="fig"} and [d](#F6){ref-type="fig"}\].

![Von Kossa staining showing absence of mineralization in coronal sections of *Dicer1* CKO palatal region at E17.5. a. WT. b. *Dicer1* CKO. Boxed region is magnified in (c, d). T: tongue; PS: lateral palatal shelves; SP: secondary palate. Bar = 500 μm](IJHG-18-310-g006){#F6}

### Cell proliferation and apoptosis in the Dicer1 CKO mouse {#sec3-10}

To investigate possible mechanism (s) associated with impaired palatal outgrowth in *Dicer1* CKO, pregnant mice were injected with EdU at E11.5, E13.5, and E17.5 and analyzed for EdU incorporation by immunohistochemistry. At embryonic day 11.5, the total number of EdU-positive (EdU^+^) cells in the region of the developing brain and first pharyngeal arch in *Dicer1* CKO mice were markedly decreased when compared to littermate controls \[Figures [7a](#F7){ref-type="fig"}--[d](#F7){ref-type="fig"}\]. As expected, in regions outside the *Pax2* expression domain, the density of EdU^+^ cells was comparable between mutant and WT littermates \[Figures [7a](#F7){ref-type="fig"}, [b](#F7){ref-type="fig"}, detail box\]. Double staining of E11.5 *Dicer1* CKO and WT sections with EdU and ApopTag was performed \[Figures [7c](#F7){ref-type="fig"} and [d](#F7){ref-type="fig"}\]. Contrasting with WT littermates \[[Figure 7c](#F7){ref-type="fig"}\], apoptotic (ApopTag) cells were detected throughout the orofacial region of *Dicer1* CKO (data not shown) and were particularly concentrated in the developing palatal areas \[[Figure 7d](#F7){ref-type="fig"}\]. At E13.5 (*P* = 0.0081) and E17.5 (*P* = 0.0032), the density of proliferating (EdU) cells was significantly lower in *Dicer1* CKO \[Figures [8a](#F8){ref-type="fig"}--[h](#F8){ref-type="fig"}\]. Moreover, the number of apoptotic cells increased significantly at E13.5 (*P* = 0.0083) \[[Figure 8d](#F8){ref-type="fig"}, detail\]. ApopTag-positive cells were not observed in the palatal region of WT littermates at E13.5 and E17.5 nor at E17.5 in *Dicer1* CKO (data not shown). Comparative RT Q-PCR analyses of dissected palatal tissue from WT and *Dicer1* CKO mice at E11.5, E13.5, and E17.5 revealed a marked increase in the levels of apoptotic markers *Caspase 3* (*P* = 0.0003) and p53 (*P* = 0.0003) in mutant mice, particularly at E13.5. Moreover, expression levels for senescence marker p21 were also higher in *Dicer1* CKO at E11.5 (*P* = 0.0009) and E13.5 (*P* = 0.0008). At E17.5 WT control and *Dicer1* CKO animals showed comparable expression levels with the exception of p21 (*P* = 0.013), \[[Figure 9](#F9){ref-type="fig"}\].

![EdU (green) and ApopTag (red) staining in coronal sections of E11.5 *Dicer1* CKO. a, c. WT. b, d. *Dicer1* CKO. High magnification of dotted boxes shown in white inset box. NT: neural tube. Bar = 500 μm (a, b); 20μm (C, D)](IJHG-18-310-g007){#F7}

![EdU (green) and ApopTag (red) staining at later time points. Right. WT. Left. *Dicer1* CKO. Inset (d) highlights apoptosis. Boxes in (a, b), (e, f) shown in (c, d), (g, h), respectively. DAPI (blue). T: tongue; PS: palatal shelves; SP: secondary palate. Bar = 500μm](IJHG-18-310-g008){#F8}

![Comparative RT Q-PCR analysis of apoptotic (*Caspase 3* and *p53*) and quiescence (*p21*) markers in palatal tissue during development. The SDs were within 1% of the mean. ^\*^*P* \< 0.01; ^\*\*^*P* \< 0.001. Exact *P* values are provided within the results section](IJHG-18-310-g009){#F9}

### miRNA expression in palatal tissue of Dicer1 CKO {#sec3-11}

To further assess the impact of *Dicer1* deletion, we examined miRNA expression in dissected palatal tissue of *Dicer1* CKO and WT control mice at E13.5 and E17.5. The choice of miRNAs was based on previous reports implicating their role in cell proliferation, craniofacial development, and predicted target genes.\[[@ref44]--[@ref46]\] These miRNAs include miR-101b, miR-140, and miR-145. Among predicted targets, these three miRNAs have been associated with regulation of *Sox9, Col10a1, Runx1, Zeb2, Pdgfc, Foxo1, Bmp3*, and *Eya3*.\[[@ref6][@ref10][@ref33][@ref47][@ref48]\] The three miRNAs tested were found to be significantly downregulated at E13.5 (*P* = 0.0002, 0.0006, and 0.0002, respectively) and E17.5 (*P* = 0.0001, 0.0004, and 0.0001, respectively) in *Dicer1* CKO \[[Figure 10](#F10){ref-type="fig"}\].

![RT Q - PCR demonstrates differential, but significant depletion of miR-101b, -140, and -145 in *Dicer1* CKO palatal tissue during palate development. The SDs were within 1% of the mean. ^\*^*P* \< 0.001. Exact *P* values are provided within the results section](IJHG-18-310-g010){#F10}

Discussion {#sec1-4}
==========

Palatogenesis and cranioskeletal development depends on proper migration, patterning, proliferation, and differentiation of CNC cells and involve a variety of genes that must be expressed at critical levels in specific spatiotemporal sequences.\[[@ref6][@ref8][@ref49][@ref50]\] *Dicer1*-dependent miRNAs are important effectors of post-transcriptional gene regulation during embryonic development, and have been implicated in impacting neural crest survival.\[[@ref51]--[@ref53]\] Recently, a genome-wide scan in multigenerational Indian families has suggested evidence of linkage for chromosome 14q32, the region encompassing the *DICER1* gene, and nonsyndromic cleft lip and palate.\[[@ref31]\]

Early in embryogenesis, CNC cells populating the first pharyngeal arch and anterior cranial skeleton originate from an area of mid-hindbrain boundary, corresponding to the *Pax2/Pax2-Cre* expression domains.\[[@ref37][@ref38][@ref54]\] Here, we extend the results of previous studies.\[[@ref30][@ref34][@ref37][@ref55]\] showing that *Pax2-Cre* and *Dicer1* expression overlaps in the lateral palatal shelves and demonstrate that *Pax2-Cre*-mediated *Dicer1* ablation leads to a secondary palatal cleft and defects in CNC-derived skeletal elements associated with the first pharyngeal arch and anterior skull. Interestingly, formation of the primary palate, which differentiates from the frontonasal region, is not impacted.

*Pax2* is the earliest transcription factor to be expressed in the prospective mid-hindbrain area, preceding the onset of several signaling molecules, including Wnt1.\[[@ref37]\] Likewise, the *Pax2-Cre* transgene is detected in the mid-hindbrain region at E7.5, with expression in the first pharyngeal arch mesenchyme around E9.5.\[[@ref34][@ref37][@ref55]\] Mutations in *Pax2* result in loss of the midbrain and cerebellar regions,\[[@ref56]\] suggesting that *Pax2* is required for maintenance of the signaling molecules associated with mid-hindbrain and CNC cell development\[[@ref37]\] and, therefore, may be expressed in those migrating CNC cells populating the first pharyngeal arch. Hence, ectopic *Pax2-Cre* expression in the mesenchyme of the first pharyngeal arch and palatal regions of the *Pax2-Cre/Dicer1^loxP/WT^/Rosa26R* reporter mice may be reflective of the endogenous *Pax2* expression in the mid-hindbrain region from which CNC cells first originate. Expression of the endogenous *Pax2* gene appears to be downregulated in normal developing palatal tissue, but not in the *Pax2-Cre* construct, where X-gal staining is still detected in CNC-derived structures of *Pax2-Cre/Dicer1^loxP/WT^/Rosa26R* \[Figures [2a](#F2){ref-type="fig"}--[c](#F2){ref-type="fig"}\]. Further studies are needed to test this hypothesis.

Evidence for miRNA-mediated gene regulation during neural crest development has emerged from studies examining the *Wnt1-Cre/Dicer1^loxP/loxP^* mice, which exhibit defects in all neural crest-derived tissue.\[[@ref51]--[@ref53]\] In contrast, defects in the *Dicer1* CKO model are specifically limited to the secondary palates and the skeletal elements derived from CNC cells of the first pharyngeal arch and anterior skull, providing a unique model in which to study the impact of *Dicer1*-dependent miRNA depletion during secondary palatogenesis.

During craniofacial morphogenesis, cell cycle progression and exit are tightly coordinated to ensure that cellular proliferation, differentiation, and apoptosis occur in the appropriate spatiotemporal sequence.\[[@ref2]\] *Dicer1* in turn regulates all these processes by mediating the biogenesis of small RNAs, including miRNAs.\[[@ref17][@ref57]\] While all three miRNAs examined were found to be significantly downregulated, residual expression was still observed and may be reflective of differential cellular *Dicer1* retention in both *Pax2-Cre* and non-*Pax2-Cre* expressing cells and/or delayed depletion of mature *Dicer1* mRNA.\[[@ref30]\]

To date, a number of *Dicer1* CKO models have been generated that confirm the importance of *Dicer1* in different aspects of cell growth and death.\[[@ref30][@ref51]--[@ref53]\] Parallel to these studies, we show here that *Pax2-Cre*-mediated loss of *Dicer1* early in craniofacial development impairs proliferation, differentiation, and survival of CNC-derived craniofacial structures associated with the first pharyngeal arch and anterior cranial base. While proliferating cells were still detectable in many regions of the face and developing brain of *Dicer1* CKO at different time points, they were less abundant compared to the WT animals, particularly in the developing palatal shelves. Moreover, the number of apoptotic cells and the expression levels for the senescence marker *p21* and the apoptotic markers *Caspase 3* and *p53* in the developing palatal shelves increased significantly as the embryos developed, supporting our earlier observation that *Dicer1* ablation may not affect CNC cell migration and initial proliferation. Rather, we hypothesize that *Dicer1* deletion in the *Pax2-Cre* expression domain contributes to premature cell cycle exit and cell death during palatogenesis. This hypothesis is consistent with previous studies showing that that progenitor cells are less dependent on miRNAs than their differentiated progeny.\[[@ref58]\] Therefore, lack of *Dicer1* and, consequently mature miRNAs in the mid-hindbrain boundary would not impact CNC cell migration to the first pharyngeal arch, but rather impair the growth and differentiation of the resultant CNC-derived mesenchyme and the formation of skeletal elements associated with the craniofacial region.

Alterations in the mandible are known to cause abnormal displacement of the tongue, which mechanically prevents the elevation of the palatal shelves, and leads to palatal clefting.\[[@ref59][@ref60]\] In the case of mechanical hindrance, mandibular hypoplasia is the notable defect and is not associated with additional craniofacial abnormalities. In contrast, palatal clefting associated with mandibular hypoplasia and abrogated growth of cranioskeletal components, such as those seen in *Dicer1* CKO and other mouse models, is often attributed to impaired cell proliferation and/or cell survival.\[[@ref50][@ref61]--[@ref63]\] Therefore, we hypothesize palatal clefting in *Dicer1* CKO is resultant of arrested palatal growth caused by decreased proliferation and increased apoptosis, rather than as a consequence of mandibular hypoplasia. This premise is supported by histological, proliferation and apoptosis assays, showing comparable palatal development in *Dicer1* CKO and WT mice up to E11.5, followed by a significant increase in apoptosis in *Dicer1* CKO palatal shelves at E13.5. Palatal growth arrest is more conspicuous at E17.5 in *Dicer1* CKO. At this time point, palatal shelves are vertically oriented, similar in size to stage E13.5 WT, exhibiting limited mesenchymal condensation, and complete absence of mineralization. These data suggest that *Pax2*-mediated deletion of *Dicer1* may prevent differentiation of CNC-derived mesenchymal cells into osteoblasts and account for the abrogated skeletal development observed in the *Dicer1* CKO facial skeleton and anterior skull.

As a whole, this study highlights the developmental impact of inhibiting miRNA biogenesis following *Dicer1* deletion in the *Pax2-Cre* expression domain and reinforces their importance for regulating the signaling pathways involved in the differentiation of CNC-derived skeleton of the first pharyngeal arch. Analyses of specific miRNA species in orofacial development, combined with targeted and controlled manipulation of those miRNA, are likely to enhance our ability to develop future therapies aiming to treat orofacial malformations.
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